TRIANA Biomedicines
PrivateLast Round
Series B
Dec 3, 2025
Est. Valuation
$258M
Total Funding Raised
$350M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
TRIANA Biomedicines is a biotechnology company that discovers and develops molecular glue therapeutics to target and degrade disease-causing proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TRIANA Biomedicines Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
TRIANA Biomedicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 3, 2025 | ||||
| Series B | Dec 3, 2024 | ||||
| Series A | Apr 6, 2022 |
Key People
Founding team and executive leadership
TRIANA Biomedicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series B, Series A |
| RA Capital Management | Series B, Seed, Series A |
| Finchley Healthcare Ventures | Series B |
| Invus Opportunities | Series B |
| Logos Capital | Series A |
| Accomplice | Series B |
| Citadel | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors increased 149% MoM, reaching 6.2K.
- Apr 15, 2026
Presenting candidate TRI-611 at AACR Annual Meeting 2026.
TRIANA Biomedicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TRIANA Biomedicines's valuation, stock price, and market status.